Results 291 to 300 of about 232,710 (307)

PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer

Radiation Oncology Investigations, 1999
Nelson Stone, Richard Stock
exaly  

Consensus statement: Guidelines for PSA following radiation therapy

, 1997
J. Cox, D. Grignon, R. Kaplan, J. Parsons, P. Schellhammer   +4 more
semanticscholar   +1 more source

PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer.

Clinical Genitourinary Cancer, 2015
S. Burgio, V. Conteduca, B. Rudnas, F. Carrozza, E. Campadelli, E. Bianchi, P. Fabbri, M. Montanari, E. Carretta, C. Menna, U. de Giorgi   +10 more
semanticscholar   +1 more source

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Journal of the American Medical Association (JAMA), 2005
MD Ian M. Thompson, PhD Donna Pauler Ankerst, MS Chen Chi, M. Scott, MS Phyllis J. Goodman, PhD John J. Crowley, MD Howard L. Parnes, J. M. CHARLES A. COLTMAN, Ankerst Drs Thompson, Mss Chi, Goodman, A. Thompson, Coltman Parnes, L. G. Thompson, Chi Ankerst, Crowley. Lucia Goodman, A. Thompson, A. C. Thompson   +17 more
semanticscholar   +1 more source

PSA

2010
openaire   +2 more sources

Clinical evaluation of free PSA/Total PSA (Prostate-specific Antigen) ratio in the diagnosis of prostate cancer

European Journal of Cancer, 1997
J Alcover, A M Ballesta, X Filella
exaly  

PSA

2011
openaire   +2 more sources

PSA

2006
openaire   +2 more sources

Literate PSA modeling for a modular PSA

2011
openaire   +1 more source

PSA

2017
openaire   +1 more source